1 domain / 2 areas / 1 specialization
Netherlands Pharmacovigilance Centre Lareb
Also known as: Lareb
National pharmacovigilance centre for the Netherlands supporting adverse drug reaction reporting, signal detection, and patient-reporting channels. Public psychedelic-specific evidence views are limited; this profile is included as core safety infrastructure.
Real-World Data Snapshot
Verification
Verified
Coverage
1 country
Access Model
Open access
Last Verified
Apr 7, 2026
Methodology
Lareb receives spontaneous reports from professionals and patients and performs causality and signal analysis in national pharmacovigilance workflows linked to EU reporting pathways.
Primary Dataset
View Lareb OverviewSource Evidence
3 sourcesAbout Lareb
https://www.lareb.nl/en/pages/about-lareb/
Lareb education and patient reporting
https://www.lareb.nl/en/pages/education-and-patient-reporting
Government of the Netherlands ADR reporting via Lareb
https://www.government.nl/topics/medicines/monitoring-the-quality-and-safety-of-medicines/reporting-an-adverse-reaction-to-a-medicinal-product-or-vaccine
Quick Facts
- Website
- Visit